No Data
10-Q: Q2 2024 Earnings Report
10-Q: Q1 2024 Earnings Report
Express News | News On Avista Public Acquisition Corp. II (AHPA,OABIV) Now Under OABI
OmniAb Announces Completion of Spin-Off and Business Combination
Ligand Announces That Janssen Has Received Approval From U.S FDA For Tecvayli For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma; Under The Terms OmniAb Is Eligible To Receive A $25M Milestone Payment Upon The First Commercial Sale
SPAC APAC Shareholders Approve Merger With Ligand Spinoff OmniAb
No Data
No Data
Anonymous Investor : Dude. Volume is ABSOLUTELY DEAD not worth it
unless shorts are involved